ããã¯ãã¼ã¯ãã¾ãã ããã«ãã¤ã¼ãå 容ãè¨è¼ããã¾ã https://b.hatena.ne.jp/URLã¯spanã§å²ãã§ãã ãã Twitterã§å ±æ

ã¢ã¤ãã«ãã¹ã¿ã¼ ããªãªã³ã©ã¤ãï¼ ã·ã¢ã¿ã¼ãã¤ãºã«ã¦2018å¹´12æï½2019å¹´1æã«æ¸¡ãéå¬ããã¾ããããã£ã¹ãã£ã³ã°æç¥¨ä¼ç»ãTHE@TER CHALLENGE!!ãã®ææ³ã»æ¯ãè¿ãã®ã¾ã¨ãã§ãã
ããããã®ãã¢ð @7WJp_Ebou ãã®ã¼ãã¸ã§ã¼ã人éãä¹ã£åããã¨ãã¦ãæ°ä¸ã®ã¤ã¤ãã³ã«éªéãããããå¯çå ãæ©éæ»ã«ããã«ãªã£ããã¨ãã§å¤±æãããã©ãç¬ä¹ã£åãããã¯ããã£ï¼ããã¤ãä¹ã£åãã°ãããããªï¼ãã£ã¦ããã¾ãèªåèªèº«ã®å¤±æããå§ã¾ã£ã¦ããããª
ç³å·åªå®#ãã§ããµã¤ãã許ããªãð¯ðµðð¥ºðð @ishikawa_yumi ç§ã¯ãã¤ã女æ§ãä»äºã§ãã¼ã«ããã³ãã¹ãå±¥ããªãããããªãã¨ãã風ç¿ããªããããã¨æã£ã¦ãã®ã å°éã®æããã«ã«æ³ã¾ãè¾¼ã¿ã§ï¼ã¶æãã¤ãããã®ã ãã©ãã³ãã¹ã§è¶³ããããã¡ã§ãå°éããããããªãã§è¶³æªæããªããä»äºããªãããããªããã ãããç·ã®äººã¯ãºããããã¤ãªã®ã«ã ç³å·åªå®#ãã§ããµã¤ãã許ããªãð¯ðµðð¥ºðð @ishikawa_yumi ä»ã®ãã¤ãã大好ãã ãã©ãã³ãã¹ã¯ã»ãã¨ãã¤ããããããªããã°ã©ãã ãåããããããè¶³é³æ°ã«ããªãã¦ããããè¶³çããªããªãã¦æ¸ããããã¤ããã®é¢¨ç¿ãªãããã ãå±¥ããã人ã¯ãã¡ããå±¥ãã¦ãã ããã
Executive Summary çµ±è¨ã®ä¿¡é ¼æ§ã«ã¤ãã¦çåãåããæ³ä¸æ¯ ä¸éã®ãã¤ã¼ããã山形ã¯ä¸è¹´ããããããã®å¾å¤å´çµ±è¨ã®éè¨æ¹æ³ã®ä¸åãé²è¦ãããããããããã®çµ±è¨ã¯æé ã§ããããããç¸é¢ãã¦ãããªããã¹ã¦ã®çµ±è¨ãæé ã ãã¨ããæ¥µè«ãè¿°ã¹ãããã°ãåºãããããçµ±è¨ã¯ãä¸ãã¼ãããå®ç§ããã¹ã¦æé ããã¨ãããã®ã§ã¯ãªããã¾ããã®ç¸äºã®é¢ä¿ããæ©æ¢°çãªé¢ä¿ãããã¨ãããã¨ã§ã¯ãªããä¿¡é ¼æ§ã®é常ã«åºãå¹ ã®ä¸ã§ä¸ä¸ããã ããªã®ã§ãå®éã«ã©ããªä¸åããã£ã¦ã©ã®ãããå½±é¿ãåã¼ãã®ããå ·ä½çã«èããªãã¨ã妥彿§ã®ãªãé°è¬è«ã«æµãã¦ãã¾ãã ãã ã ã¯ããã« ãã°ããåã«ãæ³ä¸æ¯ ä¸éããããªãã¤ã¼ããããã ã¢ãããã¯ã¹ã§çµæ¸ããããªã£ã¦ãã¨ãã£ããããªãã¬æ´¾ã®æ¹ã ã¯ããªã財åçã®åºãçµæ¸ææ¨ã¯æé ããã¦ãªãã¨ä¿¡ããããã®ã ããããâ Kiichiro Yanashita (@kiichiro)
ã示è«ãæç«ãããã¨å¼è·äººä¸èµ·è¨´ã«ãªã£ãçç±ããæ¤å¯ã¯æããã«ãã¦ããªãã䏿¹ãé«çããã®å¼è·äººã¯ãã¡ãã£ã¢ã«å¯¾ãã¦ã³ã¡ã³ããçºè¡¨ããããã®ä¸ã«ã¯ã次ã®ãããªä¸æãããã ã被害è ã¨ããã女æ§ã¨ã®ç¤ºè«æç«ãèæ ®ããããã¨ã¯äºå®ã¨æãã¾ãããããããåãã®ã¨ããã強姦è´å·ç½ªã¯è¢«å®³è ã®å訴ããªãã¦ã起訴ã§ããé大ç¯ç½ªã§ãããæªè³ªæ§ãä½ãã¨ããç¯ç½ªã®æç«ãçããããªã©ã®äºæ ããªãéãã起訴ã¯å ãã¾ããããéãæãã°åå¼ãã¦ãããããªã©ã¨ããç°¡åãªãã®ã§ã¯ããã¾ããã 示è«ã¨ã¯ãç¸æã«æ °è¬æãæ¯æã£ãããè¬ç½ªããããã¦ãè£å¤å¤ã§åè§£ãããã¨ã ãä»åãé«çããå´ã¨å¥³æ§ã®éã§ã©ããªç¤ºè«ã交ããããã®ãããã®å 容ã¯å ¬è¡¨ããã¦ããªãã é親å罪ã ãã»ã»ã»ã³ã¡ã³ãã«ãããéãã強姦è´å·ç½ªã¯ã«ã¼ã«ä¸ã被害è ã®å訴ããªãã¦ã起訴ãããã¨ãã§ããã ãã å®éã«ã¯ã被害è ã®ååããªããã°ãç¯ç½ªãç«è¨¼ãããã¨ã¯é£ãã
ç¦å²¡çå ã®ã³ã³ããã¨ã³ã¹ã¹ãã¢ã§ãã³ã¼ãã¼ç¨ã®100åã®ã«ãããè³¼å ¥ãã62æ³ã®ç·ãããã®ã«ããã®ä¸ã«150åã®ã«ãã§ã©ããæ³¨ãã çªçã®çãã§é®æããã ã®ã ããã ã 第ä¸å ±ã¯ãã¤ãã¿ã¼ã®ã¿ã¤ã ã©ã¤ã³ã«æµãã¦ãããNHKãã¥ã¼ã¹ãã®å ¬å¼ãã¤ãã¿ã¼ã® RT ãéãã¦ç¥ã£ãã ãªã³ã¯å ã§ç´¹ä»ããã¦ãããã¥ã¼ã¹ã®åç»ã§ã¯ãç¾å°ã®ã³ã³ããã®é§è»å ´ã«ç«ã£ãè¥ãè¨è ãããè¨ã£ã¦ããã ããã¡ãã®ç½ãã«ããã100åã®ã³ã¼ãã¼ç¨ã«ãããããã¦ãã¡ãã®è¶è²ãã«ããã150åã®ã«ãã§ã©ãç¨ã«ããã§ããç·ã¯ãã¡ãã®ç½ã100åã®ã«ããã«150åã®ã«ãã§ã©ããå ¥ããã¨ãããã¨ã§ãã ãªãã»ã©ã åçãçµããå¾ããã°ããèãè¾¼ãã§ãã¾ã£ãã ãè¦ããã«éãã«ããã«ã«ãã§ã©ããæ³¨ããã¨ã§50ååã®ä»£éããã§ãã¾ããã62æ³ã®ç·ï¼âãªã¬ã¨åãå¹´ã ï¼ããã¾ãããã¨ãããã¨ãªãã ãããã©ãããã¯ããã¥ã¼ã¹ããªã®ã ãããã
ãããèªãã§æãåºããã®ã ããç°ä¸è§æ ãæ¥æ¬åå³¶æ¹é è«ãï¼1972å¹´ï¼ã¯ãã¾ã®ç®ç·ã§èªãã¨ããªããªãå«èãæ·±ãããhttps://t.co/x0iGpJu0WC
人質ã®äº¤æ¸ã¨ããã®ã¯ãæåéãçæ»ãããã£ã¦ãããã¨ãå¤ãã§ããã§ããããç¸æãã³ã³ããã¼ã«ããè¨ç·´ãåãã¦ãã交æ¸ã®å°éå®¶ã¯ã人ã®è©±ãèãæ¹æ³ã«ã¤ãã¦çç¥ãã¦ãã¾ãã 人ã説å¾ãã5ã¤ã®ã¹ãããã¸ã£ã¼ããªã¹ãã®Masada Siegelããã¤ã¹ã©ã¨ã«å½é²è»ã§äººè³ªäº¤æ¸äººã¨ãã¦åãã¦ããGlenn Cohenã«ã¤ã³ã¿ãã¥ã¼ããã¦ãã¾ãããThe Wall Street Journalã«è¼ã£ã¦ããCohenã®è©±ã«ããã¨ã人質ã®äº¤æ¸ã«ã¯5ã¤ã®æ®µéãããã®ã ããã§ãã å¾è´ãå ±æã親å¯ãå½±é¿ãã大ããªç®çã§ãããè¡åã®å¤åãï¼ä¾ï¼éä¼ããããã¨ï¼ã¸ã¨å°ãã¾ããCohenã¯ããã®æåã®4ã¤ãé£ã°ãã¦ã人質ãåã£ã¦ãã人éã®è©±ãèããã«è¡åãå¤ãããã¨ããã®ããä¸çªå¤§ããªå¤±æã ã¨è¨ãã¾ãã 誰ãã®äººçãããã£ã¦ãããããªå±éºã§ä¸å®å®ãªç¶æ³ã«è¿éã¯ããã¾ããã人質ãåã£ã¦ãã人éããç²¾ç¥çã«ã身ä½çã«ã
ãã¯ã·ã£ãéå¶ããSNSãmixiãã¯2004å¹´ã®ãµã¼ãã¹éå§ããæ¥æé·ãã11å¹´ã«ã¯ã¢ã¯ãã£ãã¦ã¼ã¶ã¼ã1500ä¸äººãçªç ´ãããããã®å¾ã¯Twitterãªã©ã»ãã®SNSãå°é ãã¦å©ç¨è ãæ¥æ¸ãã¢ã«ã¦ã³ãã¯ãããããå©ç¨ãã¦ããªãâå¹½éä¼å¡âã大夿°ã¨ã¿ãããã ã ãmixiã¯çµãã£ã¦ããªããæ¨å¹´9æï½10æã«ãã¯ã·ã£ãè¡ã£ãå©ç¨è ã¢ã³ã±ã¼ãã«ããã¨ãç¾å¨ãå©ç¨ãã¦ããã¦ã¼ã¶ã¼ã®ãã¡ãæ¯æ¥å©ç¨ãã¦ãã人ã¯7å²ã«ä¸ãã¨ãããã¦ã¼ã¶ã¼è¦æ¨¡ã¯ç¸®å°ããããã¾ã 使ã£ã¦ããã¦ã¼ã¶ã¼ã®éã§ã¯ãæ¿å¯ãªã³ãã¥ãã±ã¼ã·ã§ã³ãè¡ããã¦ããããã ã ã¢ã³ã±ã¼ãã¯æ¨å¹´9æ28æ¥ï½10æ12æ¥ã«ããWebã§è¡ãã1879人ããåçãå¾ãã mixiãå©ç¨ãã¦ãã人ã®å©ç¨å¹´æ°ã¯ã10年以ä¸ãã®ããã©ã³ãéåæ°ã®57.9ï¼ ãæ§å¥ã¯ãç·æ§ã52.2ï¼ ã¨ç·æ§ãããå¤ãã£ããä½ãã§ããå°åã¯ã颿±ãã44.3ï¼ ã¨æå¤ãå©ç¨é »åº¦
æ¥æ¬çµæ¸æ°èã®åç©é£è¼ãç§ã®å±¥æ´æ¸ããç¾å¨é£è¼ä¸ã®ç³åé¦å¤«æ°(æ±äº¬æµ·ä¸æ¥åç«ç½å 社é·)ã«ã¤ãã¦ãçµå¶å¦è ã®æ¥ æ¨å»ºæ°ããæ¡å¤ãã«ã¤ã¾ããªããã¨è©ãã¦è©±é¡ãéãã¦ãããã©ããâæ¡å¤ãâãªã®ãââã â 1ã«æã®é£è¼ã§ãã®äººã®ã»ã³ã¹ãç¥ããã¨ãã§ãã æ¥æ¬çµæ¸æ°èæåé¢ã®é£è¼èªã¿ç©ãç§ã®å±¥æ´æ¸ããç¿æ £çã«èªãã§ãã人ã¯å¤ããåããã®ä¸äººã ã大ããªäºãæãã人ã ãèªãã®ä»äºã¨äººçãæ¯ãè¿ããä¸äººã§1ã«æé£è¼ãç¶ãã®ãããããã®æ³¢ä¹±ä¸ä¸ã®äººçããã£ãããã£ããã¨è¿½ä½é¨ã§ããã çµå¶è ãç»å ´ãããã¨ãå°ãªããªããå¦è ã¨ããä»äºæãçµå¶è ã®èªä¼ãåå¼·ã«ãªãã¨ãããã¨ãããã®ã ããåããç§ã®å±¥æ´æ¸ããèªãåæ©ã¯ããã以ä¸ã«åæãåãéãã人ã ã®ãã»ã³ã¹ããç¥ããã¨ã«ããã ãã®äººã®ã»ã³ã¹ã¯ã¹ãã«ãè¶ ããã¨ããã«ããããããã§ããããããã§ãããã¨ãã£ã¦ãããã¡ã¯ã¾ã ã¾ã ãæ¬å½ã®ããã¨ã¯è¨ããªããä½äººããã£ã¦
å»å¸«ã»å»å¦å士ãMBAããã¤ãºæ ªå¼ä¼ç¤¾ä»£è¡¨åç· å½¹ç¤¾é·ã 1972å¹´å¥è¯ççã¾ãã éæ²¢å¤§å¦å»å¦é¨åæ¥ãéæ²¢å¤§å¦å¤§å¦é¢å»å¦ç ç©¶ç§ä¿®äºãéæ²¢å¤§å¦å»å¦é¨åæ¥å¾ãéæ²¢å¤§å¦ç¬¬ä¸å¤ç§(ç¾ã»å é²ç·åå¤ç§)ã«å ¥å±ãã大å¦ç é¢ãåºå¹¹ç é¢ãä¸å¿ã«ã主ã«è¸é¨å¤ç§(èºãããå¿èç ãªã©)ã«å¾äºããæ¥ã æè¡ã«æãæ®ããããã®å¾ãéæ²¢å¤§å¦å¤§å¦é¢ã«å ¥å¦ããå¤ç§ç çå¦ãå°æ»ãå»å¦å士ãåå¾ãããã«ãç çå°éå»ãåå¾ããå¸ä¸ç é¢ã«ã¦ç çå»ã¨ãã¦ç æ°ã®æçµè¨ºæã«ãããããå¹´é10000件以ä¸ã®é大ç¾ç ã®è¨ºæãããªãã ã¾ããå»å¸«ã¨ãã¦åãã¤ã¤æ ¶æç¾©å¡¾å¤§å¦å¤§å¦é¢çµå¶ç®¡çç ç©¶ç§(æ ¶æãã¸ãã¹ã»ã¹ã¯ã¼ã«)ã«ã¦å»çæ¿çã»ç é¢çµå¶ã®ç¬¬ä¸äººè ã®ç°ä¸æ»ææã«å¸«äºãåãã¸ãã¹ã»ã¹ã¯ã¼ã«ãé¦å¸ã§ä¿®äºããã©ã³ã¹ã°ã©ã³ã¼ã³ã¼ã«ESSEC大å¦é¢äº¤æçå¦ããã¸ãã¹ã»ã¹ã¯ã¼ã«å¨å¦ä¸ã«å»çæ©é¢åçã³ã³ãµã«ãã£ã³ã°ä¼ç¤¾ãè¨ç«ã夿°ã®å»çæ©é¢ã®çµå¶æ¯æ´ããã«ã¹
ã¤ã¼ãã¤ã³ã§é£²ã¿ãã®ã ãè²·ã£ã¦èªåã§ä½ã£ã¦ããå¼å½é£ã£ã¦ãOLãããããã ã ãããåä¸å «ä¹ããã ä¼ç¤¾ã«å± å ´æããªãã¦é£¯ã社å ã§é£ããããªããã 㪠å¤ç¬ã極ããã£ã¦ã女ã¯ç¬é¡ã§è©±ããããã ãã§ããã ãã10åºèè¿ãåã£ã¦ãï¼ç¬ï¼
ãã®ãã³ãã¯ãã«ã«ãµããªã¼ã¯ãåæçµæãè¸ã¾ãã¤ã¤ãæ¿çç嫿ãä¸å¿ã«å¤§èã«è¨è¿°ãããã®ã§ãDPã»PDPã®ä¸é¨åã§ã¯ããã¾ãããåæå 容ã®è©³ç´°ã¯DPã»PDPæ¬æããèªã¿ãã ãããã¾ããããã«è¿°ã¹ããã¦ããè¦è§£ã¯å·çè å人ã®è²¬ä»»ã§çºè¡¨ãããã®ã§ãããæå±ããçµç¹ããã³ï¼ç¬ï¼çµæ¸ç£æ¥ç ç©¶æã¨ãã¦ã®è¦è§£ã示ããã®ã§ã¯ããã¾ããã æ¿çå²ã»æ¿çè©ä¾¡ããã°ã©ã ï¼ç¬¬åæï¼2016ã2019å¹´åº¦ï¼ ãæ¥æ¬ã«ãããã¨ããã³ã¹ã«åºã¥ãæ¿çã®æ¨é²ãããã¸ã§ã¯ã 1. è«æã®èæ¯ è¿å¹´ãçµæ¸å¦è ãç¾å®ç¤¾ä¼ã§æ¿çã®å®é¨ãå§ãã¦ããããã®éã«ãã°ãã°ç¨ããããç ç©¶ãã¶ã¤ã³ã«ãã©ã³ãã 忝è¼è©¦é¨ï¼Randomized Controlled Trial: RCTï¼ãããããããã¯ã人éããå®¶åºãã伿¥ããªã©ãã©ã³ãã ï¼ç¡ä½çºï¼ã«åãã¦2ã¤ä»¥ä¸ã®ã°ã«ã¼ããä½ãã1ã¤ã¾ãã¯ãã以ä¸ã®ã°ã«ã¼ãã®ã¿ã«æ¿çã試ããæ¿çã試ããªã
@Sankei_news ç¾ä»£æ¥æ¬ã§ãå°å¦æ ¡ã«éããªãå ç«¥ãªã©ãã¾ããããã¨ããè²§å°ãã¨è¨ãããå®¶åºã§ããã妿 ¡ã«éããªãå ç«¥ãªã©åå¨ãã¾ãããä¸ä¸ãå°±å¦å®æ ã確èªã§ããªããã°ã話é¡ã«ãªãããã¥ã¼ã¹å ±éããã¾ãããã®æ ç»ã¯è«¸å¤å½ã«â¦ https://t.co/RSqYKHOeuW
ç´ï¼ï¼å¹´ã¶ãã¨ãªãå¸ç«ä¸å¦ã®æ¨æºæã®è¦ç´ããé²ãç¦å²¡å¸ã§ï¼ï¼æ¥ãçå¾ãã¡ã®æè¦ãè´ãæ¤è¨å§å¡ä¼ãéããããåå ããï¼ï¼äººã®å¸ç«ä¸å¦çãåã¤ã®ã¡ã¼ã«ã¼ã®ãµã³ãã«ã試çãæ°ãã«æ¡ç¨ãããæ¹éã®å¥³åç¨ã¹ã©ãã¯ã¹ãè©ä¾¡ãã声ãä¸ãã£ãã å妿 ¡ãå®ããå¶æã¯ãç¾å¨å¤§å¤æ°ãè©°ãè¥ãã»ã¼ã©ã¼æãå ããããå¸ã¯æ¥æ¥ããç·å¥³ã¨ããã¬ã¶ã¼ã¿ã¤ããæ¨æºæã«ããæ¹éãæãå¯ã対çã®ã»ãã«æ§çå°æ°è ã¸ã®é æ ®ãããã女åãã¹ã©ãã¯ã¹ãæ°ãã«æ¡ç¨ããããã¨ã«ãªããã¹ã«ã¼ãã¨ã®é¸æãå¯è½ã«ãªãã ãã®æ¥ãã¹ã©ãã¯ã¹ã試çãã女åçå¾ãã¡ã¯ããã¡ããã¡ã軽ãããæé¤ã®ã¨ããã¹ã«ã¼ãã®è£¾ãæ°ã«ããªãã¦ããããæ¥½ããã»ã¼ã©ã¼æã¨å ¨ç¶éãããªã©ã¨ææ³ãè¿°ã¹ã¦ããã æè¦äº¤æã®å ´ã§ã¯ãéè¦ãã¦ã»ãããã¨ã¨ãã¦ã身軽ãªãã®ãããã¿ã³ãå°ãªãçè±ãããããã®ãã¨ãã声ãå¤ãä¸ãã£ãããªãã«ã¯ãç·åã¯ãºãã³ã女åã¯ã¹ã«ã¼ãã¨ããåºå®æ¦
è¡è¤æä¸é¦ç¸è£ä½å®ã¯24æ¥ãæ±äº¬é½å ã§éãããå ±åéä¿¡å ç社è«èª¬ç ç©¶ä¼ã§è¬æ¼ããã5æã®æ°å¤©çå³ä½ã«ä¼´ãæ¹å ã§ã4æ1æ¥ã«å ¬è¡¨ãããæ°å å·ã«é¢ããä»åã¯åªã«æããæéããªãããæ¥æ¬ã¯ããä¸åãå æ°ãåºãããã¨ããæ¹åã§é¸ã°ããã®ã§ã¯ãªãããã¨äºæ³ãããååã¯æå天çéå»ã«ããæ¹å ã ã£ãããä»åã¯å¤©çéä¸ã®éä½ã¨ç太åãã¾ã®å³ä½ã«ããç¥è³ã ã¼ãã®ä¸ã§è¡ããããã¨ãçç±ã¨ããã æ°å å·ã®é¸å®ã«é¢ããæèè ä¼è°ã«ã¯çµãè¾¼ãã 3æ¡ã示ãããã¨æãããä¸ã¤ã§ãæ¼ãããããã«ãªã£ã¦æ¬¡ã®æ¡ã«ä»£ããã ãããã¨èªã£ãã
ãæ¯æå¤å´çµ±è¨ãããããåçå´åçã®ä¸æ£èª¿æ»åé¡ããããæ¿åºãï¼ï¼ããåºå¹¹çµ±è¨ã驿£ã«èª¿æ»ããã¦ãããç¹æ¤ããçµæãï¼å²ã«ãããï¼ï¼çµ±è¨ã«è¨ï¼ï¼ä»¶ã®ééããªã©ä½ããã®åé¡ããã£ããã¨ãï¼ï¼æ¥ãããã£ãããã®ãã¡çµ±è¨æ³éåã«è©²å½ããå¯è½æ§ãããééããï¼ï¼çµ±è¨ãã£ãã ç¹æ¤çµæãã¾ã¨ããç·åçã忥çºè¡¨ãããï¼ï¼æ¥å¤ã«è¨è ä¼è¦ããä¸å® ä¿å ã»ç·åçæ¿ççµ±æ¬å®ã¯ããï¼éå°çµ¦ä»ã«ã¤ãªãã£ãï¼æ¯æå¤å´çµ±è¨ã®ãããªé大ãªäºæ¡ã¯ãªãã£ããã¨ãã¦ããããæ¿åºã®çµ±è¨ã®åãæ±ãã®ãããããæ¹ãã¦æµ®ã彫ãã«ãªã£ãå½¢ã ãçµ±è¨ãæç®¡ããåçã¯ä»å¾ã調æ»çµæãåçã®çµ±è¨å§å¡ä¼ã«è«®ããï¼ï¼ï¼ããä¸è¬çµ±è¨ãå«ãã¦ç¹æ¤ããåçºé²æ¢çãæ¢ããå°éé¨ä¼ããæ°ãã«ä½ãæ¹éã ãã¼ã¿ã®æ°å¤ã«èª¤ãããã£ãã®ã¯å½å交éçã®ã建è¨å·¥äºçµ±è¨ããï¼äºæ¥è ãæ½å·¥é«ãªã©ããç¾ä¸ååä½ãã§æ¸ãã¹ãã¨ããããä¸ååä½ãã§è¨å ¥ãããããå ¬è¡¨ããå ¨ä½ã®
çµç¹ã§ãªã¼ãã¼ãé¸ã¶éã常ã«å ã ã¨æ¯ãèããæºãããªãææãæã¤äººæãåè£ã«ãªããã¡ã§ãããã ãå¤ãã®ç ç©¶ã示ãããã«ãåªãããªã¼ãã¼ã®è³è³ªã¯ããã¨çéã§ãããåµé åã¨æè»æ§ãå ¼ãåããä½äºã«ãèªåãªãã®æè¦ãæã¡ãªãããééã£ã¦ããã°ãã®èããããå¤ãããããããªäººéã§ãããæ¬è¨äºã§ã¯ãèªåã®ç¾ç¶ãæ£ããèªèããããã®è©ä¾¡æ¹æ³ã示ããããã§ããããããªã¼ãã¼ã«å¤ããããã®å ·ä½çãªè¡åãæç¤ºãããã ãã³ã¸ã£ãã³ã»ãã©ã³ã¯ãªã³ã¯ãèªåãè³¢ããã¨ããããå¨å²ã®ã»ã¨ãã©èª°ãããè³¢ããã¨ãæ¿ç¥ãã¦ãããããããä¸äºã«ããã¦èªåãæ£ããããã§ã¯ãªãã¨çè§£ããã ãã®ãç¥æ§ãæã¡åããã¦ããã ããã«ãåè«ããã¨ãã«ã¯å¿ ããç§ãééã£ã¦ãããããããªããâ¦â¦ãã¨åç½®ããã¦è©±ãå§ããããã®ãã¬ã¼ãºã¯ç¸æãå®å¿ãããæè¦ã®ç¸éãç¸æã¸ã®åäººæ»æã ã¨åéããããªãããã®ä¸å©ã¨ãªã£ããã¾ãå½¼èªèº«ã«ã¨ã£ã¦ããæ°
NO HARD WORK!ãç¡é§ã¼ãã§çµæãåºãã¼ããã®åãæ¹ (æ©å·æ¸æ¿) ä½è : ã¸ã§ã¤ã½ã³ããªã¼ã,ãã¤ã´ã£ãããã¤ããã¤ã¤ã¼ãã³ã½ã³ åºç社/ã¡ã¼ã«ã¼: æ©å·æ¸æ¿ çºå£²æ¥: 2019/01/31 ã¡ãã£ã¢: Kindleç ãã®ååãå«ãããã°ãè¦ã ãã®æ¬ãèªãã ç®çãããã ç§ã¯ãã®æ¬ãæ¸ããäººã®æå±ããBasecampç¤¾ï¼æ§37signalsï¼ã®ãã¡ã³ã§ãæ°ååºã¦ããèè ã¯ããã¾ã§ãèªãã§ãã¾ãããç§ã®åµæ¥ããMisocaç¤¾ãæ®æ¥0ã ã£ããããªã¢ã¼ãã¯ã¼ã¯ãåãå ¥ãã¦ããã®ããã®ä¼ç¤¾ã®å½±é¿ã§ãã ç¹ã«ãGetting Realãããå°ããªãã¼ã ã大ããªä»äºãå®å ¨çã: 37ã·ã°ãã«ãºæåã®æ³åãçºè¡¨ãããæã¯ããå°ãããããéãã½ããã¦ã§ã¢ãä½ããã¨ããèãæ¹ã«å¤§ããå½±é¿ããã¦å人ãµã¼ãã¹ãä½ãåååã«ãªãã¾ããã ã¾ãæ©ããããªã¢ã¼ãã¯ã¼ã¯ï¼å¼·ããã¼ã ã¯ãªãã£ã¹ãæ¨ã¦ãï¼ã
Alex Tabarrok, âBorder Crimeâï¼Marginal Revolution, January 8, 2019ï¼ ã±ã¤ãã¼ç ç©¶æã®ã¢ã¬ãã¯ã¹ã»ãã¦ã©ã¹ãæ°ã¯ãã¡ãã·ã³å½å¢æ²¿ãã«ä½ç½®ããé¡ã®ç¯ç½ªçã¯ãå ¨ç±³ã®ãã®ä»å°åã¨æ¯è¼ãã¦ä½ãã¨è¿°ã¹ã¦ããã ããã¢ã¡ãªã«å ¨åã®ç¯ç½ªçãå½å¢æ²¿ãå°åã®2017å¹´ã®ãã®ã¨åçã§ãã£ããªãã°ã殺人äºä»¶ã¯33.8ï¼ ãçªçäºä»¶ã¯2.1ï¼ ãããã¦æ´åäºä»¶ã¯8ï¼ ä½ãã£ãã ããã ãã¡ãããå½å¢æ²¿ãã®é¡ã¯å½å¢ã«æ¥ãã¦ããªãé¡ã«æ¯ã¹ãã¨ãã£ã¨ç°èã§ãããªã©ã®éãããããã¨ã¯ãããéæ³ç§»æ°ã¨ã¢ã¡ãªã«å½æ°ï¼American Bloodï¼ã«ã¤ãã¦ã®æ¿ããã¬ããªãã¯ã«æ¯ã¹ãã¨ãããã¤ãã®äºå®ã¯è¡æçã ã
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}